Details for Patent: 6,528,540
✉ Email this page to a colleague
Summary for Patent: 6,528,540
Title: | Esmolol formulation |
Abstract: | An aqueous, sterile pharmaceutical composition suitable for parenteral administration for the treatment of cardiac conditions, comprising methyl-3-[4-(2-hydroxy-3-isopropylamino)propoxy]phenylpropionate hydrochloride (esmolol hydrochloride), a buffering agent and an osmotic-adjusting agent, as well as a method for its manufacture, are disclosed. |
Inventor(s): | Liu; Jie (Scotch Plains, NJ), Pejaver; Satish K. (Bridgewater, NJ), Owoo; George (North Plainfield, NJ) |
Assignee: | Baxter International Inc. (Deerfield, IL) |
Application Number: | 10/016,260 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 6,528,540 |
Patent Claim Types: see list of patent claims | Use; Composition; Compound; Dosage form; Formulation; Process; |
Drugs Protected by US Patent 6,528,540
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,528,540
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 035416 | ⤷ Sign Up | |||
Argentina | 098013 | ⤷ Sign Up | |||
Austria | 341319 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |